Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Endocrine
Published in: Endocrine 3/2014

01-12-2014 | Meta-Analysis

Meta-analysis of the association of ADIPOQ G276T polymorphism with insulin resistance and blood glucose

Authors: Shengrong Ouyang, Dingding Cao, Zhuo Liu, Feifei Ma, Jianxin Wu

Published in: Endocrine | Issue 3/2014

Login to get access

Abstract

Insulin resistance (IR) is a major risk for the development of type 2 diabetes (T2D). Numerous studies have been conducted to determine the relationship of ADIPOQ G276T with IR and blood glucose, but the results are conflicting. We conducted a meta-analysis in this work to further investigate such an association. Published works were retrieved from PubMed and Embase databases. A pooled standardized mean difference (SMD) with 95 % confidence interval (CI) was calculated under a dominant model using a random effect model. Twenty-five studies involving 7,480 subjects were included in the meta-analysis. A significant association of G276T polymorphism with homeostasis model assessment insulin resistance index (HOMA-IR) was observed after excluding studies with obvious heterogeneity by performing influence analysis (SMD = −0. 08, 95 % CI −0.15 to −0.01, p = 0.019) and Galbraith plot analysis (SMD = −0.08, 95 % CI −0.14 to −0.02, p = 0.005). In the subgroup analysis, Asians with TG/TT genotypes were found to have a significantly decreased degree of HOMA-IR (SMD = −0.13, 95 % CI −0.20 to −0.07, p < 0.001). The association of G276T with IR or blood glucose for the subgroups (obese, male, and T2D) was also significant. However, the results may not be reliable for small sample sizes. The current meta-analysis suggested that the G276T polymorphism may genetically affect IR using HOMA-IR as an index, and the effect of this polymorphism on IR particularly exists in Asians.
Appendix
Available only for authorised users
Literature
1.
D.J. Kim, N.H. Cho, J.H. Noh, H.J. Kim, Y.H. Choi, J.H. Jung et al., Fasting plasma glucose cutoff value for the prediction of future diabetes development: a study of middle-aged Koreans in a health promotion center. J. Korean Med. Sci. 20, 562–565 (2005)PubMedCentralPubMedCrossRef
2.
B.J. Goldstein, Insulin resistance as the core defect in type 2 diabetes mellitus. Am. J. Cardiol. 90, 3G–10G (2002)PubMedCrossRef
3.
M.M. Mercado, J.C. McLenithan, K.D. Silver, A.R. Shuldiner, Genetics of insulin resistance. Curr Diab Rep. 2, 83–95 (2002)PubMedCrossRef
4.
A.H. Kissebah, G.E. Sonnenberg, J. Myklebust, M. Goldstein, K. Broman, R.G. James et al., Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. Proc. Natl. Acad. Sci. USA 97, 14478–14483 (2000)PubMedCentralPubMedCrossRef
5.
M. Stumvoll, O. Tschritter, A. Fritsche, H. Staiger, W. Renn, M. Weisser et al., Association of the T–G polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity: interaction with family history of type 2 diabetes. Diabetes 51, 37–41 (2002)PubMedCrossRef
6.
Y. Jang, J.S. Chae, S.J. Koh, Y.J. Hyun, J.Y. Kim, Y.J. Jeong et al., The influence of the adiponectin gene on adiponectin concentrations and parameters of metabolic syndrome in non-diabetic Korean women. Clin. Chim. Acta 391, 85–90 (2008)PubMedCrossRef
7.
K. Hara, P. Boutin, Y. Mori, K. Tobe, C. Dina, K. Yasuda et al., Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 51, 536–540 (2002)PubMedCrossRef
8.
T. Kadowaki, T. Yamauchi, N. Kubota, K. Hara, K. Ueki, K. Tobe, Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest. 116, 1784–1792 (2006)PubMedCentralPubMedCrossRef
9.
D. Cao, S. Ouyang, Z. Liu, F. Ma, J. Wu, Association of the ADIPOQ T45G polymorphism with insulin resistance and blood glucose: a meta-analysis. Endocr. J. (2014). doi:10.​1507/​endocrj.​EJ13-0444
10.
C. Menzaghi, T. Ercolino, R. Di Paola, A.H. Berg, J.H. Warram, P.E. Scherer et al., A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes 51, 2306–2312 (2002)PubMedCrossRef
11.
Y. Jang, J.H. Lee, J.S. Chae, O.Y. Kim, S.J. Koh, J.Y. Kim et al., Association of the 276G->T polymorphism of the adiponectin gene with cardiovascular disease risk factors in nondiabetic Koreans. Am. J. Clin. Nutr. 82, 760–767 (2005)PubMed
12.
E.S. Kang, S.Y. Park, H.J. Kim, C.W. Ahn, M. Nam, B.S. Cha et al., The influence of adiponectin gene polymorphism on the rosiglitazone response in patients with type 2 diabetes. Diabetes Care 28, 1139–1144 (2005)PubMedCrossRef
13.
Y.Y. Lee, N.S. Lee, Y.M. Cho, M.K. Moon, H.S. Jung, Y.J. Park et al., Genetic association study of adiponectin polymorphisms with risk of Type 2 diabetes mellitus in Korean population. Diabet. Med. 22, 569–575 (2005)PubMedCrossRef
14.
K. Nakatani, K. Noma, J. Nishioka, Y. Kasai, K. Morioka, A. Katsuki et al., Adiponectin gene variation associates with the increasing risk of type 2 diabetes in non-diabetic Japanese subjects. Int. J. Mol. Med. 15, 173–177 (2005)PubMed
15.
L.B. Tanko, A. Siddiq, C. Lecoeur, P.J. Larsen, C. Christiansen, A. Walley et al., ACDC/adiponectin and PPAR-gamma gene polymorphisms: implications for features of obesity. Obes. Res. 13, 2113–2121 (2005)PubMedCrossRef
16.
M.J. Shin, Y. Jang, S.J. Koh, J.S. Chae, O.Y. Kim, J.E. Lee et al., The association of SNP276G > T at adiponectin gene with circulating adiponectin and insulin resistance in response to mild weight loss. Int. J. Obes. (Lond). 30, 1702–1708 (2006)CrossRef
17.
H. Huang, K. Tada, Iida, H. Murakami, Y. Saito, T. Otsuki, M. Iemitsu et al., Influence of adiponectin gene polymorphism SNP276 (G/T) on adiponectin in response to exercise training. Endocr. J. 54, 879–886 (2007)PubMedCrossRef
18.
G. Musso, R. Gambino, F. De Michieli, M. Durazzo, G. Pagano, M. Cassader, Adiponectin gene polymorphisms modulate acute adiponectin response to dietary fat: possible pathogenetic role in NASH. Hepatology 47, 1167–1177 (2008)PubMedCrossRef
19.
P. Perez-Martinez, J. Lopez-Miranda, C. Cruz-Teno, J. Delgado-Lista, Y. Jimenez-Gomez, J.M. Fernandez et al., Adiponectin gene variants are associated with insulin sensitivity in response to dietary fat consumption in Caucasian men. J. Nutr. 138, 1609–1614 (2008)PubMedCentralPubMed
20.
N. Zhang, Y.H. Shi, C.F. Hao, H.F. Gu, Y. Li, Y.R. Zhao et al., Association of +45G15G(T/G) and +276(G/T) polymorphisms in the ADIPOQ gene with polycystic ovary syndrome among Han Chinese women. Eur. J. Endocrinol. 158, 255–260 (2008)PubMedCrossRef
21.
H.K. Chung, J.S. Chae, Y.J. Hyun, J.K. Paik, J.Y. Kim, Y. Jang et al., Influence of adiponectin gene polymorphisms on adiponectin level and insulin resistance index in response to dietary intervention in overweight-obese patients with impaired fasting glucose or newly diagnosed type 2 diabetes. Diabetes Care 32, 552–558 (2009)PubMedCentralPubMedCrossRef
22.
L. Melistas, C.S. Mantzoros, M. Kontogianni, S. Antonopoulou, J.M. Ordovas, N. Yiannakouris, Association of the +45T>G and +276G>T polymorphisms in the adiponectin gene with insulin resistance in nondiabetic Greek women. Eur. J. Endocrinol. 161, 845–852 (2009)PubMedCentralPubMedCrossRef
23.
E. Verduci, S. Scaglioni, C. Agostoni, G. Radaelli, M. Biondi, A.S. Manso et al., The relationship of insulin resistance with SNP 276G>T at adiponectin gene and plasma long-chain polyunsaturated fatty acids in obese children. Pediatr. Res. 66, 346–349 (2009)PubMedCrossRef
24.
C.L. Passariello, R. Gruodyte, K. Hiio, J. Maestu, J. Jurimae, M. Saar et al., ADIPOQ SNP45 associated with lean body mass in physically active normal weight adolescent girls. Am. J. Hum. Biol. 22, 813–818 (2010)PubMedCrossRef
25.
R.M. Al Khaldi, F. Al Mulla, S. Al Awadhi, K. Kapila, O.A. Mojiminiyi, Associations of single nucleotide polymorphisms in the adiponectin gene with adiponectin levels and cardio-metabolic risk factors in patients with cancer. Dis. Markers 30, 197–212 (2011)PubMedCentralPubMedCrossRef
26.
I. Boumaiza, A. Omezzine, J. Rejeb, L. Rebhi, N.B. Rejeb, N. Nabli et al., Association between eight adiponectin polymorphisms, obesity, and metabolic syndrome parameters in Tunisian volunteers. Metab. Syndr. Relat. Disord. 9, 419–426 (2011)PubMedCrossRef
27.
J. Duran-Gonzalez, I. Ortiz, E. Gonzales, N. Ruiz, M. Ortiz, A. Gonzalez et al., Association study of candidate gene polymorphisms and obesity in a young Mexican-American population from South Texas. Arch. Med. Res. 42, 523–531 (2011)PubMedCentralPubMedCrossRef
28.
N.M. Al-Daghri, O.S. Al-Attas, M.S. Alokail, K.M. Alkharfy, T. Hussain, S. Yakout et al., Adiponectin gene polymorphisms (T45G and G276T), adiponectin levels and risk for metabolic diseases in an Arab population. Gene 493, 142–147 (2012)PubMedCrossRef
29.
M. Ohara, C. Maesawa, N. Takebe, T. Takahashi, M. Yamashina, M. Ono et al., Different susceptibility to insulin resistance and fatty liver depending on the combination of TNF-alpha C-857T and adiponectin G + 276T gene polymorphisms in Japanese subjects with type 2 diabetes. Tohoku J. Exp. Med. 226, 161–169 (2012)PubMedCrossRef
30.
P. Riestra, A. Garcia-Anguita, M.A. Lasuncion, A. Mangas, M. de Oya, C. Garces, Influence of the interaction between the adiponectin G276T polymorphism and body mass index on lipid levels in healthy children. Mol. Biol. Rep. 39, 4831–4835 (2012)PubMedCrossRef
31.
32.
J. Lau, J.P. Ioannidis, C.H. Schmid, Quantitative synthesis in systematic reviews. Ann. Intern. Med. 127, 820–826 (1997)PubMedCrossRef
33.
34.
35.
F. Mousavinasab, T. Tahtinen, J. Jokelainen, P. Koskela, M. Vanhala, J. Oikarinen et al., Common polymorphisms (single-nucleotide polymorphisms SNP+45 and SNP+276) of the adiponectin gene regulate serum adiponectin concentrations and blood pressure in young Finnish men. Mol. Genet. Metab. 87, 147–151 (2006)PubMedCrossRef
36.
V.W. Wong, G.L. Wong, S.W. Tsang, A.Y. Hui, A.W. Chan, P.C. Choi et al., Genetic polymorphisms of adiponectin and tumor necrosis factor-alpha and nonalcoholic fatty liver disease in Chinese people. J. Gastroenterol. Hepatol. 23, 914–921 (2008)PubMedCrossRef
37.
A. AlSaleh, S.D. O’Dell, G.S. Frost, B.A. Griffin, J.A. Lovegrove, S.A. Jebb et al., Single nucleotide polymorphisms at the ADIPOQ gene locus interact with age and dietary intake of fat to determine serum adiponectin in subjects at risk of the metabolic syndrome. Am. J. Clin. Nutr. 94, 262–269 (2011)PubMedCentralPubMedCrossRef
38.
K. Yoshioka, T. Yoshida, T. Umekawa, A. Kogure, Y. Takakura, H. Toda et al., Adiponectin gene polymorphism (G276T) is not associated with incipient diabetic nephropathy in Japanese type 2 diabetic patients. Metabolism 53, 1223–1226 (2004)PubMedCrossRef
39.
E. Filippi, F. Sentinelli, V. Trischitta, S. Romeo, M. Arca, F. Leonetti et al., Association of the human adiponectin gene and insulin resistance. Eur. J. Hum. Genet. 12, 199–205 (2004)PubMedCrossRef
40.
N. Xita, I. Georgiou, A. Chatzikyriakidou, M. Vounatsou, G.P. Papassotiriou, I. Papassotiriou et al., Effect of adiponectin gene polymorphisms on circulating adiponectin and insulin resistance indexes in women with polycystic ovary syndrome. Clin. Chem. 51, 416–423 (2005)PubMedCrossRef
41.
V. Mackevics, I.M. Heid, S.A. Wagner, P. Cip, H. Doppelmayr, A. Lejnieks et al., The adiponectin gene is associated with adiponectin levels but not with characteristics of the insulin resistance syndrome in healthy Caucasians. Eur. J. Hum. Genet. 14, 349–356 (2006)PubMedCrossRef
42.
U. Salmenniemi, J. Zacharova, E. Ruotsalainen, I. Vauhkonen, J. Pihlajamaki, S. Kainulainen et al., Association of adiponectin level and variants in the adiponectin gene with glucose metabolism, energy expenditure, and cytokines in offspring of type 2 diabetic patients. J. Clin. Endocrinol. Metab. 90, 4216–4223 (2005)PubMedCrossRef
43.
C. Menzaghi, V. Trischitta, A. Doria, Genetic influences of adiponectin on insulin resistance, type 2 diabetes, and cardiovascular disease. Diabetes 56, 1198–1209 (2007)PubMedCrossRef
44.
S. Li, L. Li, K. Li, X. Qi, D. Hoekema, H. Liu et al., Association of adipose most abundant transcript 1 gene (apM1) with type 2 diabetes mellitus in a Chinese population: a meta-analysis of case-control studies. Clin. Endocrinol. (Oxf). 68, 885–889 (2008)PubMedCrossRef
45.
H. Chu, M. Wang, D. Zhong, D. Shi, L. Ma, N. Tong et al., AdipoQ polymorphisms are associated with type 2 diabetes mellitus: a meta-analysis study. Diabetes Metab. Res. Rev. 29, 532–545 (2013)PubMed
46.
L.Y. Han, Q.H. Wu, M.L. Jiao, Y.H. Hao, L.B. Liang, L.J. Gao et al., Associations between single-nucleotide polymorphisms (+45T>G, +276G>T, −11377C>G, −11391G>A) of adiponectin gene and type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetologia 54, 2303–2314 (2011)PubMedCrossRef
47.
Y. Li, X. Li, L. Shi, M. Yang, Y. Yang, W. Tao et al., Association of adiponectin SNP+45 and SNP+276 with type 2 diabetes in Han Chinese populations: a meta-analysis of 26 case-control studies. PLoS ONE 6, e19686 (2011)PubMedCentralPubMedCrossRef
48.
C. Jing, H. Xueyao, J. Linong, Meta-analysis of association studies between five candidate genes and type 2 diabetes in Chinese Han population. Endocrine 42, 307–320 (2012)PubMedCrossRef
49.
H. Jia, L. Yu, X. Guo, W. Gao, Z. Jiang, Associations of adiponectin gene polymorphisms with polycystic ovary syndrome: a meta-analysis. Endocrine 42, 299–306 (2012)PubMedCrossRef
50.
R.W. Grant, K.E. O’Brien, J.L. Waxler, J.L. Vassy, L.M. Delahanty, L.G. Bissett et al., Personalized genetic risk counseling to motivate diabetes prevention: a randomized trial. Diabetes Care 36, 13–19 (2013)PubMedCentralPubMedCrossRef
Metadata
Title
Meta-analysis of the association of ADIPOQ G276T polymorphism with insulin resistance and blood glucose
Authors
Shengrong Ouyang
Dingding Cao
Zhuo Liu
Feifei Ma
Jianxin Wu
Publication date
01-12-2014
Publisher
Springer US
Published in
Endocrine / Issue 3/2014
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-014-0317-8

Other articles of this Issue 3/2014

Endocrine 3/2014 Go to the issue

Editorial

Does a better vitamin D status help to reduce cardiovascular risks and events?

Editorial

Strict rules are needed for validation of G-protein-coupled receptor immunohistochemical studies in human tissues

Original Article

Comparison of a very low-calorie-ketogenic diet with a standard low-calorie diet in the treatment of obesity

Original Article

Neferine prevented hyperglycemia-induced endothelial cell apoptosis through suppressing ROS/Akt/NF-κB signal

Review

Unusual effects of GH deficiency in adults: a review about the effects of GH on skin, sleep, and coagulation

Viewpoint

Ultrasonography, FNA, mutations, hormones and thyroid nodule obsession in the twenty-first century: a cytopathologist’s plea for reason in the age of thyroid storm
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits